Larvol Delta - Atreca-Reports-Fourth-Quarter-and-FullYear-2021-Financial-Results-and-ATRC101-Data-Update

ATRC-101 - Atreca

Keytruda (pembrolizumab) - Merck (MSD)

https://www.globenewswire.com/news-release/2022/03/03/2396698/0/en/Atreca-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results-and-ATRC-101-Data-Update.html

Mar 3, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next